We take your privacy very seriously, please consent to the use of all cookies when visiting our website. for more information on the processing of personal data, please refer to the Privacy Policy.

Endocrinology Department
Hyperlipidemia

Disease Introduction

Disease Introduction

Risk assessment and treatment for individuals with dyslipidemia. Individualized management is implemented for different risk groups through lifestyle modification guidance and medication intervention. Medications mainly include statins, fibrates, cholesterol absorption inhibitors, PCSK9 inhibitors, niacin, bile acid sequestrants, and high-purity fish oil.

a7_mdt.png